Form4insider filings, from the source

SEC Form 4 · accession 0000932440-16-000471

EAGLE PHARMACEUTICALS, INC. · EGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jay Moorin
10% Owner
Period of report
Sep 6, 2016
Accepted (ET)
Sep 8, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock $0.001 par valueF3,F1Sep 6, 2016S12,958$62.45D4,630,299IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF4,F1Sep 6, 2016S12,224$63.25D4,618,075IBy ProQuest Investments IV, LP
Common Stock $0.001 par valueF2Sep 6, 2016S49$62.83D9,059IBy ProQuest Financial LLC
Common Stock $0.001 par valueSep 6, 2016S166$62.83D30,527IBy Jay Moorin through IRA
Common Stock $0.001 par valueF5,F1Sep 7, 2016S11,345$62.26D4,606,730IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF2Sep 7, 2016S22$62.26D9,037IBy ProQuest Financial LLC
Common Stock $0.001 par valueSep 7, 2016S75$62.26D30,452IBy Jay Moorin through IRA
Common Stock $0.001 par valueF6,F1Sep 8, 2016S33,796$62.33D4,572,934IBy ProQuest Investments IV, LP
Common Stock $0.001 par valueF2Sep 8, 2016S66$62.33D8,971IBy ProQuest Financial LLC
Common Stock $0.001 par valueSep 8, 2016S224$62.33D30,228IBy Jay Moorin through IRA

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses